While the in vitro incubation of HMGB1 triggers significant cell proliferation and migration in PASMCs, using the HMGB1 inhibitors, saquinavir and glycyrrhizn, can restore these pathogenic PAH phenotypes [59]. The gene discussed is HMGB1; the disease is pulmonary arterial hypertension.